Colombo M - Search Results

1

Treatment of chronic hepatitis C in Europe.

Colombo M, Rumi MG, Ninno ED. Colombo M, et al. J Hepatobiliary Pancreat Surg. 2003;10(2):168-71. doi: 10.1007/s00534-002-0728-4. J Hepatobiliary Pancreat Surg. 2003. PMID: 14505151

2

Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy.

Santagostino E, Rumi MG, Rivi M, Colombo M, Mannucci PM; Hepatitis Study Group of the Association of Italian Hemophilia Centers. Santagostino E, et al. Among authors: colombo m. Blood. 2002 Feb 1;99(3):1089-91. doi: 10.1182/blood.v99.3.1089. Blood. 2002. PMID: 11807019 Free article. Clinical Trial.

3

The European approach to hepatocellular carcinoma.

Colombo M, Sangiovanni A. Colombo M, et al. Hepatogastroenterology. 2002 Jan-Feb;49(43):12-6. Hepatogastroenterology. 2002. PMID: 11941934 Review.

4

Recent progress and new trends in the treatment of hepatitis B.

Alberti A, Brunetto MR, Colombo M, Craxì A. Alberti A, et al. Among authors: colombo m. J Med Virol. 2002 Jul;67(3):458-62. doi: 10.1002/jmv.10097. J Med Virol. 2002. PMID: 12116046

5

A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus.

Santagostino E, Colombo M, Rivi M, Rumi MG, Rocino A, Linari S, Mannucci PM; Study Group of the Association of Italian Hemophilia Centers. Santagostino E, et al. Among authors: colombo m. Blood. 2003 Jul 1;102(1):78-82. doi: 10.1182/blood-2002-10-3310. Epub 2003 Mar 20. Blood. 2003. PMID: 12649165 Free article.

6

Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy.

Lampertico P, Del Ninno E, Viganò M, Romeo R, Donato MF, Sablon E, Morabito A, Colombo M. Lampertico P, et al. Among authors: colombo m. Hepatology. 2003 Apr;37(4):756-63. doi: 10.1053/jhep.2003.50148. Hepatology. 2003. PMID: 12668967 Clinical Trial.

7

Etiology, natural history and treatment of hepatocellular carcinoma.

Colombo M, Sangiovanni A. Colombo M, et al. Antiviral Res. 2003 Oct;60(2):145-50. doi: 10.1016/j.antiviral.2003.08.010. Antiviral Res. 2003. PMID: 14638411 Review.

8

Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapy.

Soffredini R, Rumi MG, Parravicini ML, Ronchi G, Del Ninno E, Russo A, Colombo M. Soffredini R, et al. Among authors: colombo m. Am J Gastroenterol. 2004 Sep;99(9):1738-43. doi: 10.1111/j.1572-0241.2004.30396.x. Am J Gastroenterol. 2004. PMID: 15330912

9

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial.

Bruno S, Cammà C, Di Marco V, Rumi M, Vinci M, Camozzi M, Rebucci C, Di Bona D, Colombo M, Craxì A, Mondelli MU, Pinzello G. Bruno S, et al. Among authors: colombo m. J Hepatol. 2004 Sep;41(3):474-81. doi: 10.1016/j.jhep.2004.05.012. J Hepatol. 2004. PMID: 15336451 Clinical Trial.

10

Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.

Viganò M, Colombo M, Aroldi A, Lunghi G, Manenti E, Ponticelli C, Lampertico P. Viganò M, et al. Among authors: colombo m. Antivir Ther. 2005;10(6):709-13. Antivir Ther. 2005. PMID: 16218169 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,556 results

Search Page

Filters